Ascribing novel functions to the sarcomeric protein, myosin binding protein H (MyBPH) in cardiac sarcomere contraction

Experimental Cell Research

Volumn 331, Issue 2, 2015, Pages 338-351

  Mouton, Jomien ^a   Loos, Ben ^b   Moolman Smook, Johanna C ^a   Kinnear, Craig J ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Cardiac contractility; Cardiac myosin binding protein C; Hypertrophic cardiomyopathy; Myosin binding protein H; Protein protein interaction

Indexed keywords

BINDING PROTEIN; MUSCLE PROTEIN; MYOSIN BINDING PROTEIN C; MYOSIN BINDING PROTEIN H; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ACTIN; CARRIER PROTEIN; CYTOSKELETON PROTEIN; LC3 PROTEIN, RAT; MICROTUBULE ASSOCIATED PROTEIN; MYBPH PROTEIN, RAT; MYH7 PROTEIN, RAT; MYOSIN HEAVY CHAIN; MYOSIN-BINDING PROTEIN C; PROTEIN BINDING; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN-CONJUGATING ENZYME UBC9;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RNA INTERFERENCE; SARCOMERE; STRESS; TWO HYBRID SYSTEM; ANIMAL; CELL CULTURE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT;

RATTUS;

ACTINS; ANIMALS; AUTOPHAGY; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; PROTEIN BINDING; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SARCOMERES; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84922042515     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.11.006     Document Type: Article

References (65)

1. Frey N., Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 2003, 65:45-79. 10.1146/annurev.physiol.65.092101.142243.
2. Lorell B.H., Carabello B.A. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000, 102:470-479.
3. Uys G.M., Ramburan A., Loos B., Kinnear C.J., Korkie L.J., Mouton J., et al. Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C. BMC Cell Biol 2011, 12:18. 10.1186/1471-2121-12-18.
4. Vaughan K.T., Weber F.E., Einheber S., Fischman D.A. Molecular cloning of chicken myosin-binding protein (MyBP) H (86-kDa protein) reveals extensive homology with MyBP-C (C-protein) with conserved immunoglobulin C2 and fibronectin type III motifs. J. Biol. Chem. 1993, 268:3670-3676.
5. Vaughan K.T., Weber F.E., Ried T., Ward D.C., Reinach F.C., Fischman D.A. Human myosin-binding protein H (MyBP-H): complete primary sequence, genomic organization, and chromosomal localization. Genomics 1993, 16:34-40.
6. Yamamoto K., Moos C. The C-proteins of rabbit red, white, and cardiac muscles. J. Biol. Chem. 1983, 258:8395-8401.
7. Bennett P., Craig R., Starr R., Offer G. The ultrastructural location of C-protein, X-protein and H-protein in rabbit muscle. J. Muscle Res. Cell Motil. 1986, 7:550-567.
8. Pepe F.A., Ashton F.T., Street C., Weisel J. The myosin filament. X. Observation of nine subfilaments in transverse sections. Tissue Cell. 1986, 18:499-508.
9. Okagaki T., Weber F.E., Fischman D.A., Vaughan K.T., Mikawa T., Reinach F.C. The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J. Cell Biol. 1993, 123:619-626.
10. Schlossarek S., Englmann D.R., Sultan K.R., Sauer M., Eschenhagen T., Carrier L. Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy. Basic Res. Cardiol. 2012, 107:235. 10.1007/s00395-011-0235-3.
11. Mizushima N. Autophagy in protein and organelle turnover. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:397-402. 10.1101/sqb.2011.76.011023.
12. Dunn K.W., Kamocka M.M., McDonald J.H. A practical guide to evaluating colocalization in biological microscopy. Am. J. Physiol. Cell Physiol. 2011, 300:C723-742. 10.1152/ajpcell.00462.2010.
13. Zinchuk V., Zinchuk O., Okada T. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem. Cytochem. 2007, 40:101-111. 10.1267/ahc.07002.
14. Chen Z.-C., Yu B.-C., Chen L.-J., Cheng K.-C., Lin H.J., Cheng J.-T. Characterization of the mechanisms of the increase in PPARδ expression induced by digoxin in the heart using the H9c2 cell line: mechanism of increased PPARδ expression by digoxin. Br. J. Pharmacol. 2011, 163:390-398. 10.1111/j.1476-5381.2011.01212.x.
15. Ku P.-M., Chen L.-J., Liang J., Cheng K.-C., Li Y.-X., Cheng J.-T. Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility. Cardiovasc. Diabetol. 2011, 10:57. 10.1186/1475-2840-10-57.
16. Alyonycheva T.N., Mikawa T., Reinach F.C., Fischman D.A. Isoform-specific interaction of the myosin-binding proteins (MyBPs) with skeletal and cardiac myosin is a property of the C-terminal immunoglobulin domain. J. Biol. Chem. 1997, 272:20866-20872.
17. Nyland L.R., Palmer B.M., Chen Z., Maughan D.W., Seidman C.E., Seidman J.G., et al. Cardiac myosin binding protein-C is essential for thick-filament stability and flexural rigidity. Biophys. J. 2009, 96:3273-3280. 10.1016/j.bpj.2008.12.3946.
18. Rybakova I.N., Greaser M.L., Moss R.L. Myosin binding protein C interaction with actin: characterization and mapping of the binding site. J. Biol. Chem. 2011, 286:2008-2016. 10.1074/jbc.M110.170605.
19. Pan M.-R., Chang T.-M., Chang H.-C., Su J.-L., Wang H.-W., Hung W.-C. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells. J. Cell Sci. 2009, 122:3358-3364. 10.1242/jcs.050005.
20. Tateishi Y., Ariyoshi M., Igarashi R., Hara H., Mizuguchi K., Seto A., et al. Molecular basis for SUMOylation-dependent regulation of DNA binding activity of heat shock factor 2. J. Biol. Chem. 2009, 284:2435-2447. 10.1074/jbc.M806392200.
21. Baek S.H. A novel link between SUMO modification and cancer metastasis. Cell Cycle Georget. Tex 2006, 5:1492-1495.
22. Zhu L., Santos N.C., Kim K.H. Small ubiquitin-like modifier-2 modification of retinoic acid receptor-alpha regulates its subcellular localization and transcriptional activity. Endocrinology 2009, 150:5586-5595. 10.1210/en.2009-0868.
23. Welikson R.E., Fischman D.A. The C-terminal IgI domains of myosin-binding proteins C and H (MyBP-C and MyBP-H) are both necessary and sufficient for the intracellular crosslinking of sarcomeric myosin in transfected non-muscle cells. J. Cell Sci. 2002, 115:3517-3526.
24. Nacerddine K., Lehembre F., Bhaumik M., Artus J., Cohen-Tannoudji M., Babinet C., et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell. 2005, 9:769-779. 10.1016/j.devcel.2005.10.007.
25. Gautel M., Castiglione Morelli M.A., Pfuhl M., Motta A., Pastore A. A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. Eur. J. Biochem. FEBS 1995, 230:752-759.
26. Weisberg A., Winegrad S. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:8999-9003.
27. de Lange W.J., Grimes A.C., Hegge L.F., Ralphe J.C. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue. J. Gen. Physiol. 2012, 141:73-84. 10.1085/jgp.201210837.
28. Harris S.P., Bartley C.R., Hacker T.A., McDonald K.S., Douglas P.S., Greaser M.L., et al. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ. Res. 2002, 90:594-601.
29. Stöhr A., Friedrich F.W., Flenner F., Geertz B., Eder A., Schaaf S., et al. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. J. Mol. Cell. Cardiol. 2013, 10.1016/j.yjmcc.2013.07.011.
30. Levine R., Weisberg A., Kulikovskaya I., McClellan G., Winegrad S. Multiple structures of thick filaments in resting cardiac muscle and their influence on cross-bridge interactions. Biophys. J. 2001, 81:1070-1082. 10.1016/S0006-3495(01)75764-5.
31. Weisberg A., Winegrad S. Relation between crossbridge structure and actomyosin ATPase activity in rat heart. Circ. Res. 1998, 83:60-72.
32. Garvey J.L., Kranias E.G., Solaro R.J. Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. Biochem. J. 1988, 249:709-714.
33. Hartzell H.C., Titus L. Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton myofibrillar protein in intact cardiac muscle. J. Biol. Chem. 1982, 257:2111-2120.
34. Ababou A., Rostkova E., Mistry S., Le Masurier C., Gautel M., Pfuhl M. Myosin binding protein C positioned to play a key role in regulation of muscle contraction: structure and interactions of domain C1. J. Mol. Biol. 2008, 384:615-630. 10.1016/j.jmb.2008.09.065.
35. Shaffer J.F., Kensler R.W., Harris S.P. The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner. J. Biol. Chem. 2009, 284:12318-12327. 10.1074/jbc.M808850200.
36. Park H., Larson B.L., Kolewe M.E., Vunjak-Novakovic G., Freed L.E. Biomimetic scaffold combined with electrical stimulation and growth factor promotes tissue engineered cardiac development. Exp. Cell Res. 2014, 321:297-306. 10.1016/j.yexcr.2013.11.005.
37. Li Y., Shen D., Tang X., Li X., Wo D., Yan H., et al. Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes. Toxicol. Lett. 2014, 226:257-263. 10.1016/j.toxlet.2014.02.016.
38. Branco A.F., Sampaio S.F., Wieckowski M.R., Sardão V.A., Oliveira P.J. Mitochondrial disruption occurs downstream from β-adrenergic overactivation by isoproterenol in differentiated, but not undifferentiated H9c2 cardiomyoblasts: differential activation of stress and survival pathways. Int. J. Biochem. Cell Biol. 2013, 45:2379-2391. 10.1016/j.biocel.2013.08.006.
39. Zhang Q., Yan L., Weiss H.R., Scholz P.M. Cyclic GMP-induced reduction in cardiac myocyte function is partially mediated by activation of the sarcoplasmic reticulum Ca(2+)-ATPase. Pharmacology 2002, 64:106-112.
40. Li S.-Y., Gilbert S.A.B., Li Q., Ren J. Aldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol ingestion-induced myocardial insulin resistance and endoplasmic reticulum stress. J. Mol. Cell. Cardiol. 2009, 47:247-255. 10.1016/j.yjmcc.2009.03.017.
41. Brickson S., Fitzsimons D.P., Pereira L., Hacker T., Valdivia H., Moss R.L. In vivo left ventricular functional capacity is compromised in cMyBP-C null mice. Am. J. Physiol. Heart Circ. Physiol 2007, 292:H1747-1754. 10.1152/ajpheart.01037.2006.
42. Carrier L., Knöll R., Vignier N., Keller D.I., Bausero P., Prudhon B., et al. Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc. Res. 2004, 63:293-304. 10.1016/j.cardiores.2004.04.009.
43. Tong C.W., Stelzer J.E., Greaser M.L., Powers P.A., Moss R.L. Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function. Circ. Res. 2008, 103:974-982. 10.1161/CIRCRESAHA.108.177683.
44. Palmer B.M., Georgakopoulos D., Janssen P.M., Wang Y., Alpert N.R., Belardi D.F., et al. Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening. Circ. Res. 2004, 94:1249-1255. 10.1161/01.RES.0000126898.95550.31.
45. Hofmann P.A., Hartzell H.C., Moss R.L. Alterations in Ca2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J. Gen. Physiol. 1991, 97:1141-1163.
46. Stelzer J.E., Patel J.R., Moss R.L. Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C. Circ. Res. 2006, 99:884-890. 10.1161/01.RES.0000245191.34690.66.
47. Stelzer J.E., Patel J.R., Walker J.W., Moss R.L. Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ. Res. 2007, 101:503-511. 10.1161/CIRCRESAHA.107.153650.
48. Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A., et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999, 285:895-898.
49. Yoshioka K. A role for LIM kinase in cancer invasion. Proc. Natl. Acad. Sci. 2003, 100:7247-7252. 10.1073/pnas.1232344100.
50. Hosono Y., Yamaguchi T., Mizutani E., Yanagisawa K., Arima C., Tomida S., et al. MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J. 2011, 31:481-493. 10.1038/emboj.2011.416.
51. Zheng Q., Li J., Wang X. Interplay between the ubiquitin-proteasome system and autophagy in proteinopathies. Int. J. Physiol. Pathophysiol. Pharmacol 2009, 1:127-142.
52. Zheng Q., Wang X. Autophagy and the ubiquitin-proteasome system in cardiac dysfunction. Panminerva Med. 2010, 52:9-25.
53. Arstila A.U., Trump B.F. Studies on cellular autophagocytosis. The formation of autophagic vacuoles in the liver after glucagon administration. Am. J. Pathol. 1968, 53:687-733.
54. Ericsson J.L. Studies on induced cellular autophagy. I. Electron microscopy of cells with in vivo labelled lysosomes. Exp. Cell Res. 1969, 55:95-106.
55. Dunn W.A. Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J. Cell Biol. 1990, 110:1923-1933.
56. Hayashi-Nishino M., Fujita N., Noda T., Yamaguchi A., Yoshimori T., Yamamoto A. A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat. Cell Biol. 2009, 11:1433-1437. 10.1038/ncb1991.
57. Ylä-Anttila P., Vihinen H., Jokitalo E., Eskelinen E.-L. 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy 2009, 5:1180-1185.
58. Fujita N., Hayashi-Nishino M., Fukumoto H., Omori H., Yamamoto A., Noda T., et al. An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol. Biol. Cell. 2008, 19:4651-4659. 10.1091/mbc.E08-03-0312.
59. Sarikas A., Carrier L., Schenke C., Doll D., Flavigny J., Lindenberg K.S., et al. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc. Res. 2005, 66:33-44. 10.1016/j.cardiores.2005.01.004.
60. Koekemoer A.L., Chong N.W., Goodall A.H., Samani N.J. Myocyte stress 1 plays an important role in cellular hypertrophy and protection against apoptosis. FEBS Lett. 2009, 583:2964-2967. 10.1016/j.febslet.2009.08.011.
61. Pereira S.L., Ramalho-Santos J., Branco A.F., Sardão V.A., Oliveira P.J., Carvalho R.A. Metabolic remodeling during H9c2 myoblast differentiation: relevance for in vitro toxicity studies. Cardiovasc. Toxicol. 2011, 11:180-190. 10.1007/s12012-011-9112-4.
62. Watkins S.J., Borthwick G.M., Arthur H.M. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. Vitro Cell. Dev. Biol.Anim 2010, 47:125-131. 10.1007/s11626-010-9368-1.
63. Kim D.-E., Kim B., Shin H.-S., Jeong Kwon H., Park E.-S. The protective effect of hispidin against hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblast cells through Akt/GSK-3β and ERK1/2 signalling pathway. Exp. Cell Res 2014, 10.1016/j.yexcr.2014.07.037.
64. Nobuhara M., Saotome M., Watanabe T., Urushida T., Katoh H., Satoh H., et al. Mitochondrial dysfunction caused by saturated fatty acid loading induces myocardial insulin-resistance in differentiated H9c2 myocytes: a novel ex vivo myocardial insulin-resistance model. Exp. Cell Res. 2013, 319:955-966. 10.1016/j.yexcr.2013.02.004.
65. Watanabe T., Saotome M., Nobuhara M., Sakamoto A., Urushida T., Katoh H., et al. Roles of mitochondrial fragmentation and reactive oxygen species in mitochondrial dysfunction and myocardial insulin resistance. Exp. Cell Res. 2014, 323:314-325. 10.1016/j.yexcr.2014.02.027.